Ajanta Pharma has reported results for first quarter ended June 30, 2024 (Q1FY25).
The company has reported 11.31% rise in net profit at Rs 236.03 crore for Q1FY25 as compared to Rs 212.04 crore for the same quarter in the previous year. Total income of the company increased by 5.69% at Rs 1,105.64 crore for Q1FY25 as compared to Rs 1,046.04 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 18.09% rise in its net profit at Rs 245.77 crore for the quarter ended June 30, 2024 as compared to Rs 208.12 crore for the same quarter in the previous year. Total income of the company increased by 11.27% at Rs 1171.39 crore for Q1FY25 as compared to Rs 1052.79 crore for the corresponding quarter previous year.
